Physician profile
Julia Sharma
NPI 1528579810
$6,956.46
in general payments reported to CMS, 2019-2025
14 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,418 · 2020: $489 · 2021: $157 · 2022: $1,716 · 2023: $101 · 2024: $950 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $645 · Travel and Lodging: $531.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $644.94 |
| Travel and Lodging | $531.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Monteris Medical Corporation | $2,689.33 | 2019-2021 | |
| Globus Medical, INC. | $1,387.63 | 2022 | |
| Neuropace, INC. | $1,125.21 | 2019-2024 | |
| Stryker Corporation | $802.60 | 2019-2025 | Universal Neuro 3, Core |
| Livanova USA, INC. | $411.31 | 2019-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Depuy Synthes Sales INC. | $177.73 | 2019-2021 | |
| Neurelis, INC. | $145.95 | 2024 | Valtoco |
| Integra Lifesciences Corporation | $64.71 | 2019-2021 | |
| Ethicon US, LLC | $54.63 | 2022 | |
| Abbvie INC. | $32.53 | 2025 | |
| Medtronic, INC. | $20.67 | 2025 | Strata |
| Aesculap, INC. | $16.78 | 2021 | |
| Novartis Pharmaceuticals Corporation | $15.48 | 2019 | |
| Greenwich Biosciences, INC. | $11.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.